A score to predict short-term risk of COPD exacerbations (SCOPEX).

Barry J Make, Göran Eriksson, Peter M Calverley, Christine R Jenkins, Dirkje S Postma, Stefan Peterson, Ollie Östlund, Antonio Anzueto

Research output: Contribution to journalArticlepeer-review

41 Citations (SciVal)
140 Downloads (Pure)


There is no clinically useful score to predict chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to derive this by analyzing data from three existing COPD clinical trials of budesonide/formoterol, formoterol, or placebo in patients with moderate-to-very-severe COPD and a history of exacerbations in the previous year.
Original languageEnglish
Pages (from-to)201-209
JournalThe International Journal of Chronic Obstructive Pulmonary Disease
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Respiratory Medicine and Allergy


Dive into the research topics of 'A score to predict short-term risk of COPD exacerbations (SCOPEX).'. Together they form a unique fingerprint.

Cite this